About Cohera Medical
Cohera Medical is a company based in Pittsburgh (United States) founded in 2006. It operates as a B2B. Cohera Medical has raised $185.42 million across 19 funding rounds from investors including KKR, HHS and Accelerator Fund. The company has 33 employees as of December 31, 2022. Cohera Medical operates in a competitive market with competitors including Neomend, GATT Technologies BV, Sealonix, OptMed and BORAYER, among others.
- Headquarter Pittsburgh, United States
- Employees 33 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Cohera Medical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$185.42 M (USD)
in 19 rounds
-
Latest Funding Round
$30 M (USD), Series E
Oct 26, 2015
-
Investors
KKR
& 5 more
-
Employee Count
33
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cohera Medical
Cohera Medical has successfully raised a total of $185.42M across 19 strategic funding rounds. The most recent funding activity was a Series E round of $30 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cohera Medical
Cohera Medical has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include KKR, HHS and Accelerator Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
US private equity investments are managed by Kern Whelan Capital.
|
Locked | Locked | Locked |
Investor details for Cohera Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cohera Medical
Investment portfolio details for Cohera Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cohera Medical
Detailed financials for Cohera Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cohera Medical Comparisons
Peer comparison for Cohera Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cohera Medical
Cohera Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neomend, GATT Technologies BV, Sealonix, OptMed and BORAYER, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of air leak sealant for thoracic surgery
|
|
| Locked | Locked | Locked |
Polymer-based adhesive tissue tape is developed for surgical sealants.
|
|
| Locked | Locked | Locked |
Developer of hemostatic sealants for surgeries
|
|
| Locked | Locked | Locked |
Biocompatible polymers and genitourinary therapeutics are developed and commercialized.
|
|
| Locked | Locked | Locked |
Biomaterials for surgery and wound repair are developed.
|
Detailed competitors of Cohera Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cohera Medical
Complete news archive for Cohera Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cohera Medical
Cohera Medical was founded in 2006.
Cohera Medical is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Cohera Medical is a funded company, having raised a total of $185.42M across 19 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Cohera Medical is 33.
Cohera Medical, founded in 2006 in Pittsburgh, United States, focuses on providing healthcare solutions, developing medical devices, surgical technologies, and adhesives and sealants. Develops innovative surgical adhesives and sealants for medical use. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Cohera Medical's top competitors include Neomend, OptMed and GATT Technologies BV.
Cohera Medical has 6 investors. Key investors include KKR, HHS, Accelerator Fund, Kern Whelan Capital, and Bradford Capital Partners.